214 related articles for article (PubMed ID: 22736789)
1. The oncogenic role of miR-155 in breast cancer.
Mattiske S; Suetani RJ; Neilsen PM; Callen DF
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1236-43. PubMed ID: 22736789
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
Li XF; Yan PJ; Shao ZM
Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.
Aydoğdu E; Katchy A; Tsouko E; Lin CY; Haldosén LA; Helguero L; Williams C
Carcinogenesis; 2012 Aug; 33(8):1502-11. PubMed ID: 22562546
[TBL] [Abstract][Full Text] [Related]
4. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer.
Uhlmann S; Zhang JD; Schwäger A; Mannsperger H; Riazalhosseini Y; Burmester S; Ward A; Korf U; Wiemann S; Sahin O
Oncogene; 2010 Jul; 29(30):4297-306. PubMed ID: 20514023
[TBL] [Abstract][Full Text] [Related]
5. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
6. Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22.
Patel JB; Appaiah HN; Burnett RM; Bhat-Nakshatri P; Wang G; Mehta R; Badve S; Thomson MJ; Hammond S; Steeg P; Liu Y; Nakshatri H
Oncogene; 2011 Mar; 30(11):1290-301. PubMed ID: 21057539
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in breast cancer pathogenesis.
Götte M
Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
[TBL] [Abstract][Full Text] [Related]
8. MiR-205 in cancer: an angel or a devil?
Qin AY; Zhang XW; Liu L; Yu JP; Li H; Wang SZ; Ren XB; Cao S
Eur J Cell Biol; 2013 Feb; 92(2):54-60. PubMed ID: 23279926
[TBL] [Abstract][Full Text] [Related]
9. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.
Zhang Y; Yan LX; Wu QN; Du ZM; Chen J; Liao DZ; Huang MY; Hou JH; Wu QL; Zeng MS; Huang WL; Zeng YX; Shao JY
Cancer Res; 2011 May; 71(10):3552-62. PubMed ID: 21444677
[TBL] [Abstract][Full Text] [Related]
10. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
Yoshimoto N; Toyama T; Takahashi S; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Breast Cancer Res Treat; 2011 Nov; 130(1):331-9. PubMed ID: 21755340
[TBL] [Abstract][Full Text] [Related]
11. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
[TBL] [Abstract][Full Text] [Related]
12. Integration of BRCA1-mediated miRNA and mRNA profiles reveals microRNA regulation of TRAF2 and NFκB pathway.
Tanic M; Zajac M; Gómez-López G; Benítez J; Martínez-Delgado B
Breast Cancer Res Treat; 2012 Jul; 134(1):41-51. PubMed ID: 22167321
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis.
Harquail J; Benzina S; Robichaud GA
Cancer Biomark; 2012; 11(6):269-80. PubMed ID: 23248185
[TBL] [Abstract][Full Text] [Related]
14. Identification of direct targets for the miR-17-92 cluster by proteomic analysis.
Kanzaki H; Ito S; Hanafusa H; Jitsumori Y; Tamaru S; Shimizu K; Ouchida M
Proteomics; 2011 Sep; 11(17):3531-9. PubMed ID: 21751348
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide identification of TCF7L2/TCF4 target miRNAs reveals a role for miR-21 in Wnt-driven epithelial cancer.
Lan F; Yue X; Han L; Shi Z; Yang Y; Pu P; Yao Z; Kang C
Int J Oncol; 2012 Feb; 40(2):519-26. PubMed ID: 21956205
[TBL] [Abstract][Full Text] [Related]
16. miR-200c enhances radiosensitivity of human breast cancer cells.
Lin J; Liu C; Gao F; Mitchel RE; Zhao L; Yang Y; Lei J; Cai J
J Cell Biochem; 2013 Mar; 114(3):606-15. PubMed ID: 22991189
[TBL] [Abstract][Full Text] [Related]
17. A bioinformatics approach for identification of miR-100 targets implicated in breast cancer.
Shamsi R; Seifi-Alan M; Behmanesh A; Omrani MD; Mirfakhraie R; Ghafouri-Fard S
Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):99-105. PubMed ID: 29096749
[TBL] [Abstract][Full Text] [Related]
18. The diverse role of miR-31 in regulating cancer associated phenotypes.
Laurila EM; Kallioniemi A
Genes Chromosomes Cancer; 2013 Dec; 52(12):1103-13. PubMed ID: 23999990
[TBL] [Abstract][Full Text] [Related]
19. miR-205 in Breast Cancer: State of the Art.
Plantamura I; Cataldo A; Cosentino G; Iorio MV
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375067
[TBL] [Abstract][Full Text] [Related]
20. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.
Goh JN; Loo SY; Datta A; Siveen KS; Yap WN; Cai W; Shin EM; Wang C; Kim JE; Chan M; Dharmarajan AM; Lee AS; Lobie PE; Yap CT; Kumar AP
Biol Rev Camb Philos Soc; 2016 May; 91(2):409-28. PubMed ID: 25631495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
